Allergan pursuers get expedited trial over special meeting date

|About: Allergan plc (AGN)|By:, SA News Editor

Delaware Court of Chancery Chancellor Andre Bouchard orders a three-day trial to begin October 6, 2014 to settle the issue of the timing of the Allergan (AGN -0.8%) special shareholders meeting sought by Valeant Pharmaceuticals (VRX -0.8%) and Pershing Square Capital Management. Allergan scheduled the meeting for December 18, 2014 but its pursuers wanted mid-November so they filed suit to resolve the issue. Unsurprisingly, Allergan wanted the trial to start later. It preferred a November 24 start.